Intratumorally delivered formulation, INT230-6, containing potent anticancer agents induces protective T cell immunity and memory.

Bloom, Anja C; Bender, Lewis H; Tiwary, Shweta; Pasquet, Lise; Clark, Katharine; Jiang, Tianbo; Xia, Zheng; Morales-Kastresana, Aizea; Jones, Jennifer C; Walters, Ian; Terabe, Masaki; Berzofsky, Jay A

Bloom, Anja C; Bender, Lewis H; Tiwary, Shweta; Pasquet, Lise; Clark, Katharine; Jiang, Tianbo; Xia, Zheng; Morales-Kastresana, Aizea; Jones, Jennifer C; Walters, Ian; Terabe, Masaki; Berzofsky, Jay A.

Bloom AC; Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Bender LH; Intensity Therapeutics, Westport, CT, USA.
Tiwary S; Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Pasquet L; Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Clark K; Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Jiang T; Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Xia Z; Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Morales-Kastresana A; Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Jones JC; Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Walters I; Intensity Therapeutics, Westport, CT, USA.
Terabe M; Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Berzofsky JA; Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.